WNT1 and chronic myelogenous leukemia, BCR-ABL1 positive: – β-catenin is a target of BCR-ABL (Zhao et al., 2007; Tomasello et al., 2020) – Wnt1 signaling supports growth and survival of CML cells (Majeti et al., 2009).